← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Ipsen
-4.64%
Pharma / Pharmaceuticals, Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 1.34 | 1.15 | 0.45 | 1.49 | 168.43 | 169.92 | 504.29 | -334.37 | 0.83 | 0.14 | 0.12 | 0.1 | 0.17 | 0.05 | 0.08 | 0.1 | 0.8 | 0.87 | 0.14 | 0.07 | 0.1 | 0.06 | 0.09 | 20.87 | 2.15 | 1.54 | 244.83 | 0.72 | 2.17 | 5.38 | 0.56 | 11.06 | 1.61 | 8.21 | 0.29 | 0.26 | 0.15 | 2.15 | 1525.83 | 1.17 | 1.04 | 0.29 | 2.19 | 2.19 | 2.56 | 26.49 | 68.89 | 10.01 | 10.01 | -0.57 | 2.56 | 0.01 | 7.67 | 2.19 |
2023-12 | 1.17 | 0.99 | 0.32 | 69.69 | 184.99 | 254.68 | 492.93 | -238.25 | 0.83 | 0.25 | 0.23 | 0.19 | 0.18 | 0.1 | 0.17 | 0.17 | 0.85 | 0.93 | 0.25 | 0.05 | 0.08 | 0.07 | 0.07 | 42.06 | 2.83 | 1.65 | 5.24 | 0.74 | 1.97 | 5.75 | 0.52 | 10.47 | 9.06 | 6.39 | 0.15 | 0.26 | 0.87 | 2.83 | 96.21 | 7.45 | 4.01 | 0.15 | 2.33 | 2.33 | 2.7 | 13.85 | 11.91 | 10.31 | 10.31 | 1.69 | 2.7 | 0.01 | 7.61 | 2.33 |
2022-12 | 1.8 | 1.58 | 0.88 | 73.14 | 196.51 | 269.65 | 447.59 | -177.94 | 0.83 | 0.3 | 0.22 | 0.21 | 0.16 | 0.12 | 0.19 | 0.22 | 0.92 | 0.75 | 0.3 | 0.14 | 0.23 | 0.15 | 0.19 | 39.65 | 1.24 | 1.68 | 4.99 | 0.82 | 1.86 | 5.43 | 0.56 | 11.47 | 8.43 | 14.45 | 0.15 | 0.3 | 0.73 | 1.24 | 12.4 | 3.77 | 2.71 | 0.15 | 2.5 | 2.5 | 2.65 | 12.87 | 11.92 | 8.76 | 8.76 | -2.24 | 2.65 | 0.01 | 7.03 | 2.5 |
2021-12 | 1.59 | 1.41 | 0.66 | 74.94 | 182.58 | 257.52 | 494.91 | -237.39 | 0.84 | 0.32 | 0.29 | 0.24 | 0.2 | 0.13 | 0.24 | 0.24 | 0.82 | 0.89 | 0.32 | 0.16 | 0.29 | 0.17 | 0.22 | 37.39 | 1.11 | 1.82 | 4.87 | 0.74 | 2 | 4.24 | 0.55 | 10.46 | 5.44 | 10.28 | 0.13 | 0.32 | 0.52 | 1.11 | 9.28 | 2.09 | 1.74 | 0.13 | 2.45 | 2.45 | 2.44 | 10.38 | 14.79 | 7.7 | 7.7 | 0.67 | 2.44 | 0.01 | 6.31 | 2.45 |
Wait! There's more — sign up for free or log in